SS INNOVATIONS INTERNATIONAL, INC. (SSII) Quick Ratio
- Quick ratio · latest quarter: Value (m); Formula and calculation Cash, cash equivalents, current marketable securities and trade receivables / current liabilities. Period ending 2026-06-30..
Quick ratio
Overview →Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| Quick ratio · latest quarter | (m) | Cash, cash equivalents, current marketable securities and trade receivables / current liabilities. Period ending 2026-06-30. Calculation unavailable: missing inputs remain (m). |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Cash, securities and trade receivables | (m) | Cash and Cash Equivalents, at Carrying Value · Accounts Receivable, after Allowance for Credit Loss, Current |
| Current obligations | 31.89M USD | Liabilities, Current |
| Cash and equivalents | 13.65M USD | Cash and Cash Equivalents, at Carrying Value |
| Short-term securities | (m) | |
| Customer receivables | 16.99M USD | Accounts Receivable, after Allowance for Credit Loss, Current |
| Inventory · excluded from quick assets | 18.48M USD | Inventory, Net |
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Cash, securities and trade receivables (USD) | Current obligations (USD) | Cash and equivalents (USD) | Short-term securities (USD) | Customer receivables (USD) | Inventory · excluded from quick assets (USD) | Quick ratio |
|---|---|---|---|---|---|---|---|
| 2026-06-30 | (m) | $31.89M | $13.65M | (m) | $16.99M | $18.48M | (m) |
| 2026-03-31 | (m) | $26.05M | $15.98M | (m) | $14.05M | $17.07M | (m) |
| 2025-12-31 | (m) | $26.24M | $3.21M | (m) | $12.40M | $17.06M | (m) |
| 2025-09-30 | (m) | $21.19M | $5.68M | (m) | $6.92M | $20.04M | (m) |
| 2025-06-30 | (m) | $19.61M | $11.38M | (m) | $5.97M | $18.26M | (m) |
| 2025-03-31 | (m) | $15.00M | $15.87M | (m) | $3.96M | $14.30M | (m) |
| 2024-12-31 | (m) | $21.33M | $466.50K | (m) | $4.47M | $10.21M | (m) |
| 2024-09-30 | (m) | $18.94M | $220.36K | (m) | $5.10M | $9.19M | (m) |
| 2024-06-30 | (m) | $17.73M | $1.45M | (m) | $4.60M | $6.44M | (m) |
| 2024-03-31 | (m) | $15.66M | $948.15K | (m) | $4.23M | $6.16M | (m) |
| 2023-12-31 | (m) | $9.27M | $2.02M | (m) | $1.65M | $6.33M | (m) |
| 2023-09-30 | (m) | $8.30M | (m) | (m) | $1.51M | $4.17M | (m) |
| 2023-06-30 | (m) | $8.37M | (m) | (m) | $1.07M | $2.61M | (m) |
| 2023-03-31 | (m) | $5.12M | (m) | (m) | (m) | (m) | (m) |
| 2022-12-31 | (m) | $4.05M | (m) | (m) | (m) | (m) | (m) |
| 2022-09-30 | (m) | $1.32M | (m) | (m) | (m) | (m) | (m) |
| 2022-06-30 | (m) | $221.59K | (m) | (m) | (m) | (m) | (m) |
| 2022-03-31 | (m) | $278.25K | (m) | (m) | (m) | (m) | (m) |
| 2021-12-31 | (m) | $287.28K | $405.77K | (m) | (m) | (m) | (m) |
| 2021-09-30 | (m) | $1.28M | (m) | (m) | (m) | (m) | (m) |
| 2021-06-30 | (m) | $1.30M | (m) | (m) | (m) | (m) | (m) |
| 2021-03-31 | (m) | $1.23M | (m) | (m) | (m) | (m) | (m) |
| 2020-12-31 | (m) | $1.19M | (m) | (m) | (m) | (m) | (m) |
| 2020-09-30 | (m) | $1.37M | (m) | (m) | (m) | (m) | (m) |
| 2020-06-30 | (m) | $1.27M | (m) | (m) | (m) | (m) | (m) |
| 2020-03-31 | (m) | $1.17M | (m) | (m) | (m) | (m) | (m) |
| 2019-12-31 | (m) | $1.20M | $28.47K | (m) | (m) | (m) | (m) |
| 2019-09-30 | (m) | $1.07M | $29.97K | (m) | (m) | (m) | (m) |
| 2019-06-30 | (m) | $883.91K | $39.09K | (m) | (m) | (m) | (m) |
| 2019-03-31 | (m) | $623.14K | $61.53K | (m) | (m) | (m) | (m) |
| 2018-12-31 | (m) | $449.78K | $35.72K | (m) | (m) | (m) | (m) |
| 2018-09-30 | (m) | $480.62K | $100.18K | (m) | (m) | (m) | (m) |
| 2018-06-30 | (m) | $318.32K | $191.69K | (m) | (m) | (m) | (m) |
| 2018-03-31 | (m) | $245.56K | $314.67K | (m) | (m) | (m) | (m) |
| 2017-12-31 | (m) | $408.87K | $452.57K | (m) | (m) | (m) | (m) |
| 2017-09-30 | (m) | $132.92K | $520.86K | (m) | (m) | (m) | (m) |
| 2017-06-30 | (m) | $631.23K | $129.56K | (m) | (m) | (m) | (m) |
| 2017-03-31 | (m) | (m) | $255.48K | (m) | (m) | (m) | (m) |
| 2016-12-31 | (m) | $647.29K | $248.22K | (m) | (m) | (m) | (m) |
| 2016-09-30 | (m) | (m) | $288.73K | (m) | (m) | (m) | (m) |
| 2016-06-30 | (m) | (m) | $370.17K | (m) | (m) | (m) | (m) |
| 2015-12-31 | (m) | (m) | $100.00 | (m) | (m) | (m) | (m) |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ORTHOPEDIATRICS CORP (KIDS) | United States | $0.592B | |
| DELCATH SYSTEMS, INC. (DCTH) | United States | $0.558B | 820.33 |
| ANGIODYNAMICS INC (ANGO) | United States | $0.632B | -13.02 |
| CERUS CORP (CERS) | United States | $0.525B | -86.40 |
| TACTILE SYSTEMS TECHNOLOGY INC (TCMD) | United States | $0.519B | 27.16 |
| MIMEDX GROUP, INC. (MDXG) | United States | $0.687B | 89.92 |
| NeuroPace Inc (NPCE) | United States | $0.480B | -28.52 |
| Sight Sciences, Inc. (SGHT) | United States | $0.478B | -9.95 |
| ClearPoint Neuro, Inc. (CLPT) | United States | $0.446B | -15.74 |
| CARLSMED, INC. (CARL) | United States | $0.405B |